Detecting Hematologic Cancers
The battle to save the immune support army in the blood
Early detection can be challenging in cases of the most common blood cancers like leukemia, lymphoma, and myeloma. Each of these diseases can interrupt a patient’s army of white blood cells, leading to a highly compromised immune system.
The Cell Marque™ IHC Antibody Portfolio offers a variety of valuable and reliable markers for your hematologic testing.
